小G蛋白Cdc42的循环类抑制剂模仿效应蛋白的结合
Natasha P Murphy1, George J N Tetley1, Jefferson Revell2
1Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Biochemistry
|January 21, 2026
概括
研究人员设计了针对Cdc42,一个小GTPase的优化抑制剂. 这些新型结合剂表现出纳米分子亲和力和独特的结合模式,为在治疗上准具有挑战性的Ras超级家族蛋白提供了有希望的策略.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 包括Cdc42在内的Ras超级家族的小GTPases,由于有限的结合口袋,很难成为治疗点.
- 之前的研究已经确定了循环化是Cdc42活性的高亲和度抑制剂.
研究的目的:
- 设计和优化Cdc42.4的第三代抑制剂.
- 阐明抑制的结合机制和结构基础,以改善治疗设计.
主要方法:
- 工程修改和选第三代循环的Cdc42抑制.
- 确定了-Cdc42复合物的晶体结构.
- 未结合的变体的解的NMR结构.
主要成果:
- 通过单个氨基酸替代实现了更好的结合亲和力.
- 揭示了一种新的结合模式,其中通过扩展GTPase的β-sheet来模仿本地效应器.
- 利用结构数据进行进一步的抑制剂的合理设计.
结论:
- 展示了一种罕见而创新的非共价结合策略,用于准Ras GTPases.
- 这些发现为开发针对具有挑战性的小G蛋白点的治疗方法提供了新的途径.
相关概念视频
Factors Affecting Protein-Drug Binding: Protein-Related Factors
534
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
534
Protein and Protein Structure
87.0K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
A protein's shape is critical to its function. For example, an enzyme...
87.0K
Protein-protein Interfaces
14.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.6K
G-protein Coupled Receptors
131.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.7K
Protein-Drug Binding: Determination Methods
630
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
630
Drug Distribution: Plasma Protein Binding
8.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.7K


